EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Mass extraction container closure integrity physical testing method development for parenteral container closure systems



Mass extraction container closure integrity physical testing method development for parenteral container closure systems



Pda Journal of Pharmaceutical Science and Technology 66(5): 403-419



Container closure integrity (CCI) is a critical factor to ensure that product sterility is maintained over its entire shelf life. Assuring the CCI during container closure (C/C) system qualification, routine manufacturing and stability is important. FDA guidance also encourages industry to develop a CCI physical testing method in lieu of sterility testing in a stability program. A mass extraction system has been developed to check CCI for a variety of container closure systems such as vials, syringes, and cartridges. Various types of defects (e.g., glass micropipette, laser drill, wire) were created and used to demonstrate a detection limit. Leakage, detected as mass flow in this study, changes as a function of defect length and diameter. Therefore, the morphology of defects has been examined in detail with fluid theories. This study demonstrated that a mass extraction system was able to distinguish between intact samples and samples with 2 μm defects reliably when the defect was exposed to air, water, placebo, or drug product (3 mg/mL concentration) solution. Also, it has been verified that the method was robust, and capable of determining the acceptance limit using 3 for syringes and 6 for vials.LAY Sterile products must maintain their sterility over their entire shelf life. Container closure systems such as those found in syringes and vials provide a seal between rubber and glass containers. This seal must be ensured to maintain product sterility. A mass extraction system has been developed to check container closure integrity for a variety of container closure systems such as vials, syringes, and cartridges. In order to demonstrate the method's capability, various types of defects (e.g., glass micropipette, laser drill, wire) were created in syringes and vials and were tested. This study demonstrated that a mass extraction system was able to distinguish between intact samples and samples with 2 μm defects reliably when the defect was exposed to air, water, placebo, or drug product (3 mg/mL concentration) solution. Also, it was verified that the method showed consistent results, and was able to determine the acceptance limit using 3 for syringes and 6 for vials.

(PDF emailed within 0-6 h: $19.90)

Accession: 036603631

Download citation: RISBibTeXText

PMID: 23035025

DOI: 10.5731/pdajpst.2012.00878



Related references

Influence of Different Container Closure Systems and Capping Process Parameters on Product Quality and Container Closure Integrity (CCI) in GMP Drug Product Manufacturing. Pda Journal of Pharmaceutical Science and Technology 70(2): 109-119, 2018

Container Closure Integrity Testing - Method Development for Freeze Dryed Products Using laser based Headspace Oxygen Analysis. Pda Journal of Pharmaceutical Science and Technology: -, 2018

Container/closure integrity of parenteral vials. Journal of Parenteral Science and Technology 41(5): 145-158, 1987

Correlation of mass spectrometry-based helium leak measurements to microbial ingress for pharmaceutical container/closure integrity testing. Pharmaceutical Research (New York) 14(11 SUPPL ): S407, 1997

Feasibility of Using Fluorescence Spectrophotometry to Develop a Sensitive Dye Immersion Method for Container Closure Integrity Testing of Prefilled Syringes. Pda Journal of Pharmaceutical Science and Technology 70(1): 39-50, 2018

Method Development for Container Closure Integrity Evaluation via Headspace Gas Ingress by Using Frequency Modulation Spectroscopy. Pda Journal of Pharmaceutical Science and Technology 71(6): 429-453, 2017

White Paper: Container Closure Integrity Control versus Integrity Testing during Routine Manufacturing. Pda Journal of Pharmaceutical Science and Technology 69(3): 461-465, 2015

Container Closure Integrity Testing of Prefilled Syringes. Journal of Pharmaceutical Sciences: -, 2018

Quantitative and mechanistic measurements of parenteral vial container/closure integrity. Leakage quantitation. Journal of Parenteral Science and Technology 43(2): 88-97, 1989

Development and validation of a spectrophotometric dye immersion test method used to measure container-closure integrity of an oil-based product. Pda Journal of Pharmaceutical Science and Technology 52(3): 110-112, 1998

Vacuum decay container closure integrity leak test method development and validation for a lyophilized product-package system. Pda Journal of Pharmaceutical Science and Technology 65(5): 486-505, 2016

Pharmaceutical container/closure integrity. V: An evaluation of the WILCO "LFC" method for leak testing pharmaceutical glass-stoppered vials. Pda Journal of Pharmaceutical Science and Technology 53(5): 235-239, 2001

Container Closure Integrity Testing-Practical Aspects and Approaches in the Pharmaceutical Industry. Pda Journal of Pharmaceutical Science and Technology 71(2): 147-162, 2016

Pharmaceutical container closure integrity by mass spectrometry-based leak detection. Pharmaceutical Research (New York) 13(9 SUPPL ): S225, 1996

Tamper indicating closure for a container container and method for making same us patent 4793122 december 27 1988. 1988